These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11432352)

  • 1. [Clinical experience of intermittent administration of 5-FU and CDDP to patients with advanced and recurrent gastric cancer].
    Sekikawa K; Anzai K; Ishihata R; Yamaki T; Ohki S; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):825-8. PubMed ID: 11432352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intermittent administration of 5-FU and isovorin to patients with advanced and recurrent colon cancer].
    Sekikawa K; Anzai K; Momma T; Yamaki T; Ando Y; Sassa M; Ito K; Endo Y; Sato N; Honda K; Hatakeyama Y; Koyama Y; Inoue N; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1009-12. PubMed ID: 11478130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose FP therapy for advanced and recurrent gastric cancer].
    Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Oyama R; Ogata Y
    Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
    Shinkai K; Kida H; Hisano H; Shibasaki S; Yano H; Nomura M
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical effect of chemotherapy with 5-FU and low-dose CDDP in patients with advanced gastric cancer].
    Murase M; Kondo K; Kodera Y; Kiriyama K; Akiyama S; Ito K; Yokoyama Y; Shirasaka T; Takagi H
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1025-8. PubMed ID: 8210252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological evaluation of neoadjuvant chemotherapy with low-dose FP therapy for advanced gastric cancer].
    Takano S; Oda K; Koda K; Seike K; Takiguchi N; Miyazaki M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):555-8. PubMed ID: 17431341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of low-dose FP therapy for advanced gastric cancer cases].
    Liu X; Gu X; Li Y; Li J; Wang P
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2081-5. PubMed ID: 10584576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of recurrent gastric cancer for which combination chemotherapy with pirarubicin, cis-platinum and 5-fluorouracil were markedly effective].
    Katsumata K; Yamamoto K; Ashizawa T; Sumi T; Yamashita S; Nagashima K; Murohashi T; Majima T; Mori M; Takahashi S; Koyanagi Y
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):113-6. PubMed ID: 10660742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon].
    Satoh Y; Une Y; Fujisawa J; Sawaguchi Y; Muranaga S; Obara M; Uchino J
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):87-92. PubMed ID: 7826083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
    Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.